Cochlear (Cochlear) Operating Cash Flow per Share : $4.38 (TTM As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Cochlear Operating Cash Flow per Share?

Cochlear's operating cash flow per share for the six months ended in Dec. 2023 was $1.60. Cochlear's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was $4.38.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Cochlear was 26.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Cochlear's Operating Cash Flow per Share or its related term are showing as below:

During the past 13 years, Cochlear's highest 3-Year average Operating Cash Flow per Share Growth Rate was 280.30% per year. The lowest was -67.80% per year. And the median was 12.90% per year.

CHEOF's 3-Year OCF Growth Rate is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 2.6
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Cochlear Operating Cash Flow per Share Historical Data

The historical data trend for Cochlear's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cochlear Operating Cash Flow per Share Chart

Cochlear Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Operating Cash Flow per Share

Get a 7-Day Free Trial

3.56

-1.83

3.16

4.02

3.69

Cochlear Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial															1.36	2.69	0.91	2.78	1.60

Competitive Comparison of Cochlear's Operating Cash Flow per Share

For the Medical Devices subindustry, Cochlear's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cochlear's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cochlear's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Cochlear's Price-to-Operating-Cash-Flow falls into.

Cochlear Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Cochlear's Operating Cash Flow per Share for the fiscal year that ended in Jun. 2023 is calculated as

Operating Cash Flow per Share (A: Jun. 2023 )	=	Cash Flow from Operations (A: Jun. 2023 )	/	Shares Outstanding (Diluted Average) (A: Jun. 2023 )
	=	243.221	/	65.907
	=	3.69

Cochlear's Operating Cash Flow per Share for the quarter that ended in Jun. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	105.154	/	65.705
	=	1.60

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $4.38

Cochlear Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Cochlear's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Cochlear (Cochlear) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cochlear Ltd (OTCPK:CHEOF) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

CHEOY:USA OC5:Germany COH:Australia

Address

1 University Avenue, Macquarie University, Sydney, NSW, AUS, 2109

Website

https://www.cochlear.com

Cochlear is the leading cochlear implant device manufacturer with around 60% global market share. Developed markets contribute 80% of group revenue where cochlear implants are the standard of care for children with severe to profound hearing loss. The company also actively targets the growing cohort of seniors in developed markets. Tender-oriented emerging markets contribute the remaining 20% of group revenue. Main products include cochlear implants, bone-anchored hearing aids, and associated sound processors. In fiscal 2020, 49% of revenue came from the Americas, 35% from Europe, the Middle East, and Africa, and 16% from the Asia-Pacific segment.